The cardiovascular risk charts. A critical review;Las tablas de riesgo cardiovascular. Una revisión crítica

MEDIFAM - Revista de Medicina Familiar y Comunitaria

Volumn 11, Issue 3, 2001, Pages 122-139

  Alvarez Cosmea A ^a  

^a NONE   (Spain)

Author keywords

Cardiovascular disease; Cardiovascular risk; Prediction; Risk factors

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; ISCHEMIC HEART DISEASE; PREDICTION; PROPHYLAXIS; REVIEW; SCORING SYSTEM; SPAIN; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 0035048865     PISSN: 11315768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Mortalidad Cardiovascular en España y sus comunidades autónomas (1975-1992)
2. Task Force Report. Prevention of coronary heart disease in clinical practice: Recommendations of the second joint task force of the joint European Societies on coronary prevention
3. Guidelines on preventing cardiovascular disease in clinical practice
4. AHA and ACC outline approaches to coronary disease risk assessment. Practice guidelines
5. An updated coronary risk profile. A statement for health professionals
6. Is the Framingham Risk Function valid for Norther European populations? A comparison of methods for estimating absolute coronary risk in high risk men
7. Estimating cardiovascular risk for primary prevention: Outstanding questions for primary care
8. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study
9. ¿Debe diseñarse una estrategia específica de prevención primaria de la cardiopatía isquémica para los países mediterráneos de Europa?
10. Primary prevention of coronary heart disease: Guidance from Framingham
11. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects without prior myocardial infarction
12. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
13. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-V)
14. Prediction of coronary heart disease using risk factor categories
15. Assessment of cardiovascular risk by use of multiple-risk-factor assesment equations. ACC/AHA scientific statement
16. Primary prevention of coronary heart disease: Selection of patiens for aggressive cholesterol management
17. Absolute risk assessment in the clinical setting
18. Prevention conference V: Beyond secondary prevention: Identifying the patient for primary prevention: Medical office assessment: Writing group
19. Riesgo cardiovascular global en ancianos
20. Primary and subsequent coronary risk appraisal: New results from the Framingham study
21. Guías de práctica clínica de la Sociedad Española de Cardiología en prevención cardiovascular y rehabilitación cardíaca
22. Control de la colesterolemia en España, 2000. Un instrumento para la prevención cardiovascular
23. Perfil lipídico de la población española: Estudio DRECE (Dieta y Riesgo de Enfermedad Cardiovascular en España)
24. Results of follow-up at 8 years
25. Joint British recommendations on prevention of coronary heart disease in clinical practice
26. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
27. New British recommendations for prevention of coronary heart disease in clinical practice
28. Updated New Zealand cardiovascular disease risk-benefit prediction guide
29. Randomised trial of cholesterol lowering in 4.444 patiets with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
30. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
31. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
32. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: An updated Sheffield table
33. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population
34. Indications for cholesterol-lowering medication: Comparison of risk-assessment methods
35. Assessing heart disease risk in primary care
36. Risk assessment in primary prevention of coronary heart disease: Randomised comparison of three scoring methods
37. Problems on the Pathway from risk assessment to risk reduction
38. Guidelines-a missed opportunity
39. Documentos de prevención cardiovascular: Una visión global